Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/22/2025

Toxicity Monitoring Guidelines

Introduction to Toxicity

  • Peripheral neuropathy and gastrointestinal neuropathies with unknown causes are associated with environmental and occupational exposure concerns, according to the American Diabetes Association 1

Patient Risk Factors

  • Individuals on long-term parenteral nutrition (>30 days), especially with impaired liver function, and children with developmental delays and environmental risk factors are at risk, as reported by the European Society for Clinical Nutrition and Metabolism 2

Monitoring and Testing

  • Manganese toxicity monitoring should not be done more frequently than at 40-day intervals, and patients on long-term parenteral nutrition with manganese require regular monitoring, especially with intake >55 μg/day, as stated by the European Society for Clinical Nutrition and Metabolism 2
  • Whole blood or serum manganese values greater than twice the upper limit of normal laboratory reference ranges indicate potential toxicity, according to the European Society for Clinical Nutrition and Metabolism 2
  • Heavy metal testing can be performed using blood, urine, hair, and nail analysis to detect metals such as arsenic, lead, mercury, and thallium, as recommended by the American Academy of Physical Medicine and Rehabilitation 3
  • Regular biological monitoring, at least yearly, is recommended for individuals receiving aluminum-containing medications, as suggested by the National Kidney Foundation 4
  • Venous blood sampling is the preferred method for most heavy metal testing, especially for lead, mercury, cadmium, and arsenic exposure assessment, as recommended by the Centers for Disease Control and Prevention 5
  • Complete 24-hour urine collection is essential for copper, mercury, arsenic, and cadmium exposure assessment, with copper levels >40 μg/24h warranting investigation for Wilson's disease, according to the American Association for the Study of Liver Diseases 6
  • The following indications for testing are recommended by the Centers for Disease Control and Prevention 6:
Indication Description
Unexplained neurological symptoms Individuals with unexplained neurological symptoms
Liver abnormalities Liver abnormalities of uncertain cause in individuals 3-45 years
Suspected occupational exposure Individuals with suspected occupational exposure to heavy metals
Environmental exposure concerns Individuals with environmental exposure concerns
Specific symptoms Specific symptoms associated with known metal toxicity
  • A combination of at least two biomarkers, including holo-transcobalamin, methylmalonic acid, and serum cobalamin, is recommended for testing, according to the Academy of Nutrition and Dietetics 2
  • Expanded panel testing can identify additional exposures missed by single-element testing, as recommended by the American Industrial Hygiene Association 2
  • Proper collection and storage techniques are necessary to prevent sample contamination, including:

Diagnostic Criteria

  • Copper values >100 μg/24 hours are typically diagnostic for Wilson's disease, according to the American Association for the Study of Liver Diseases 6, 7
  • Serum ceruloplasmin <200 mg/L or 20 mg/dL suggests deficiency, according to the National Institute of Diabetes and Digestive and Kidney Diseases 6, 7
  • 24-hour urinary copper excretion >40 μg/24h warrants investigation, as recommended by the American Association for the Study of Liver Diseases 6, 7
  • Liver biopsy is the gold standard for copper measurement in Wilson's disease, with diagnostic levels ≥250 μg/g dry weight, as stated by the American Association for the Study of Liver Diseases 6
  • D-penicillamine challenge test is used for children with suspected Wilson's disease, with >1600 μg copper/24 hours being diagnostic, as recommended by the American Association for the Study of Liver Diseases 6
  • Kayser-Fleischer rings should be sought by slit-lamp examination, and genotype or haplotype studies based on findings in the proband should be performed, as suggested by the American Association for the Study of Liver Diseases 6